Search by Drug Name or NDC
NDC 43063-0482-30 Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1 Details
Lisinopril and Hydrochlorothiazide 12.5; 10 mg/1; mg/1
Lisinopril and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is HYDROCHLOROTHIAZIDE; LISINOPRIL.
MedlinePlus Drug Summary
The combination of lisinopril and hydrochlorothiazide is used to treat high blood pressure. Lisinopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly. Hydrochlorothiazide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 43063-0482-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lisinopril and Hydrochlorothiazide
Product Information
| NDC | 43063-0482 |
|---|---|
| Product ID | 43063-482_fb5bdef3-130a-9a52-e053-6294a90a1054 |
| Associated GPIs | 36991802550305 |
| GCN Sequence Number | 021277 |
| GCN Sequence Number Description | lisinopril/hydrochlorothiazide TABLET 10-12.5 MG ORAL |
| HIC3 | A4J |
| HIC3 Description | ACE INHIBITOR-THIAZIDE OR THIAZIDE-LIKE DIURETIC |
| GCN | 88002 |
| HICL Sequence Number | 000131 |
| HICL Sequence Number Description | LISINOPRIL/HYDROCHLOROTHIAZIDE |
| Brand/Generic | Generic |
| Proprietary Name | Lisinopril and Hydrochlorothiazide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lisinopril and Hydrochlorothiazide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 12.5; 10 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | HYDROCHLOROTHIAZIDE; LISINOPRIL |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077912 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43063-0482-30 (43063048230)
| NDC Package Code | 43063-482-30 |
|---|---|
| Billing NDC | 43063048230 |
| Package | 30 TABLET in 1 BOTTLE, PLASTIC (43063-482-30) |
| Marketing Start Date | 2013-07-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |